Gordana Bogdanovic
Overview
Explore the profile of Gordana Bogdanovic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
106
Citations
2381
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leijonhufvud G, Soratto T, Matos G, Bajalan A, Eichler-Jonsson C, Gustafsson B, et al.
J Clin Virol
. 2024 Oct;
175:105736.
PMID: 39405634
Background And Objectives: A large cohort of pediatric patients with various forms of childhood cancer was investigated for the presence of viruses using metagenomics. A total of 476 patient samples,...
2.
Chen P, Bergman P, Blennow O, Hansson L, Mielke S, Nowak P, et al.
EBioMedicine
. 2024 Oct;
109:105385.
PMID: 39395230
Background: Immunocompromised patients with primary and secondary immunodeficiencies have shown impaired responses to SARS-CoV-2 mRNA vaccines, necessitating recommendations for additional booster doses. However, longitudinal data reflecting the real-world impact of...
3.
Albinsson B, Hoffman T, Kolstad L, Bergstrom T, Bogdanovic G, Heydecke A, et al.
Euro Surveill
. 2024 Jan;
29(2).
PMID: 38214080
BackgroundIn Sweden, information on seroprevalence of tick-borne encephalitis virus (TBEV) in the population, including vaccination coverage and infection, is scattered. This is largely due to the absence of a national...
4.
Yan J, Bangalore C, Nikouyan N, Appelberg S, Silva D, Yao H, et al.
Mol Ther
. 2024 Jan;
32(2):540-555.
PMID: 38213030
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific neutralizing antibodies (NAbs) lack cross-reactivity between SARS-CoV species and variants and fail to mediate long-term protection against infection. The maintained protection against severe...
5.
Andersson M, Wu J, Wullimann D, Gao Y, Aberg M, Muschiol S, et al.
J Hematol
. 2023 Sep;
12(4):170-175.
PMID: 37692865
Background: Patients with chronic lymphocytic leukemia (CLL) are vulnerable to coronavirus disease 2019 (COVID-19) and are at risk of inferior response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination,...
6.
Ingelman-Sundberg H, Blixt L, Wullimann D, Wu J, Gao Y, Healy K, et al.
Haematologica
. 2023 Aug;
109(2):646-651.
PMID: 37646668
No abstract available.
7.
Chen P, Bergman P, Blennow O, Hansson L, Mielke S, Nowak P, et al.
EBioMedicine
. 2023 Jul;
94:104700.
PMID: 37453361
Background: Immunocompromised patients have varying responses to SARS-CoV-2 mRNA vaccination. However, there is limited information available from prospective clinical trial cohorts with respect to long-term immunogenicity-related responses in these patient...
8.
Ghorbani M, Al-Manei K, Naud S, Healy K, Gabarrini G, Sobkowiak M, et al.
Front Immunol
. 2023 Jan;
13:1079995.
PMID: 36703980
Coevolution of microbiome and immunity at mucosal sites is essential for our health. Whether the oral microbiome, the second largest community after the gut, contributes to the immunogenicity of COVID-19...
9.
Blixt L, Gao Y, Wullimann D, Muren Ingelman-Sundberg H, Muschiol S, Healy K, et al.
Blood
. 2022 Sep;
140(22):2403-2407.
PMID: 36150168
No abstract available.
10.
Gao Y, Cai C, Wullimann D, Niessl J, Rivera-Ballesteros O, Chen P, et al.
Immunity
. 2022 Aug;
55(9):1732-1746.e5.
PMID: 35961317
Many immunocompromised patients mount suboptimal humoral immunity after SARS-CoV-2 mRNA vaccination. Here, we assessed the single-cell profile of SARS-CoV-2-specific T cells post-mRNA vaccination in healthy individuals and patients with various...